No insider purchase over the last 90 days. The latest was filed 24 May 2026.
Every trade that managers of Micropos Medical AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Between 18 October 2025 and 18 October 2026, 2 insiders published 3 filings.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €678k, made by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €678k, bought by Ove Mattsson and made public on 24 May 2026. Among those who bought: 1 board member.
With 3 filings in twelve months, the company is quieter than the median of 7 filings across the 885 companies we follow on the same exchange. Looking back to 2025, when coverage begins, insiders filed 1 purchase and no sales.
The last purchase on record was published on 24 May 2026, which is 146 days ago. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19).
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
· cache
4 of 4 declarations
Micropos Medical AB (publ) is a Swedish company focused on developing innovative medical solutions. It is listed on the Stockholm Stock Exchange (XSTO).